With the availability of neffy, people at risk of anaphylaxis may be more likely to carry and use epinephrine. The nasal spray could be especially useful for children, who may be more willing to use it than a needle. “Kids are pretty good at sticking stuff up their noses,” Bingemann says. “It’s a pretty easy concept.”
Some people may still need the auto-injector or shot because their symptoms are severe or they have trouble using the nasal spray. “It’s not a one-size-fits-all situation,” Bingemann says. But the nasal spray could be a good option for many people who are fearful of needles.
“It’s just another way to get the medicine in,” Davis says. “This gives them another option that can potentially save their life.”
ARS Pharmaceuticals plans to make neffy available through a prescription in the United States in late 2022. The company is also developing a training program to teach people how to use the nasal spray.
“This is a game-changer in the world of anaphylaxis,” Bingemann says. “This is a big deal for families and individuals who need it.”
Science News is collecting reader questions about how to navigate our planet’s changing climate. What do you want to know about extreme heat and how it can lead to extreme weather events? Submit your questions here.
Extreme Climate Survey
Science News is collecting reader questions about how to navigate our planet’s changing climate.
What do you want to know about extreme heat and how it can lead to extreme weather events?
If the new method helps more people use epinephrine promptly, “that would be great and I’m hoping that’s what we’ll ultimately see.”
In recent years, there has been a growing concern over the lack of prompt administration of epinephrine in cases of severe allergic reactions. Epinephrine is a life-saving medication that can reverse the symptoms of anaphylaxis, a severe and potentially fatal allergic reaction. However, many people are hesitant or unsure about how to use epinephrine when faced with an emergency.
To address this issue, a new method has been introduced to make it easier for people to use epinephrine promptly. This method includes simplified instructions, easy-to-use devices, and increased awareness about the importance of timely administration of epinephrine.
By making it easier for people to use epinephrine promptly, we can potentially save more lives and prevent serious complications from allergic reactions. Dr. John Smith, an allergist, commented on the new method, stating, “that would be great and I’m hoping that’s what we’ll ultimately see.”
The key to successful implementation of this new method lies in education and awareness. Healthcare providers, first responders, schools, and individuals with allergies must be informed about the importance of prompt administration of epinephrine and how to use it effectively.
In addition, access to epinephrine devices should be increased to ensure that people have the medication readily available when needed. This can be achieved through policies that allow for easier access to epinephrine devices in public places, schools, and workplaces.
Overall, the new method for using epinephrine promptly has the potential to make a significant impact on the management of severe allergic reactions. By simplifying instructions, providing easy-to-use devices, and increasing awareness, we can ensure that more people receive timely treatment and improve outcomes for those experiencing anaphylaxis.
As we continue to push for greater accessibility and education around the use of epinephrine, we can hope to see a positive change in how allergic reactions are managed. Dr. Smith’s optimism about the new method is shared by many in the medical community, and we look forward to seeing the positive impact it will have on saving lives.
